Buccioni Michela

Title: Buccioni Michela: Innovator in Adenosine Receptor Active Compounds

Introduction

Buccioni Michela is a notable inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target adenosine receptors. His work focuses on creating innovative solutions for various health conditions.

Latest Patents

Michela holds a patent for "7-isopropyl 1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7-tricarboxylates as adenosine receptor active compounds." This patent encompasses novel compounds, methods of synthesizing these compounds, and their applications in pharmaceutical compositions. The compounds identified as adenosine A receptor (AAR) modulators are particularly useful in treating inflammation, cancer, and ischemic conditions. They also address other adenosine overexpression-related conditions, including rheumatoid arthritis, psoriasis, and fatty liver diseases.

Career Highlights

Michela is affiliated with King Fahd University of Petroleum and Minerals, where he continues to advance his research and innovation in the pharmaceutical field. His work has garnered attention for its potential impact on treating various pathological conditions affecting both the central and peripheral nervous systems.

Collaborations

Michela collaborates with esteemed colleagues, including Katharigatta N Venugopala and Pran Kishore Deb. These partnerships enhance the research and development of new therapeutic agents.

Conclusion

Buccioni Michela's contributions to the field of adenosine receptor active compounds highlight his role as an innovator in pharmaceutical chemistry. His patented work promises to provide new avenues for treating significant health issues.